PanTera SA
24.2 FTEThe score of PanTera shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Revenue +34518 % Equity +171 % Total assets +161 % Headcount (avg FTE) +303 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PanTera's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
PanTera's financial analysis
- Solvency94.0%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PanTera
PanTera's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0784.992.591
- VAT number
- BE0784992591
- Peppol
- Registered · 0208:0784992591 · as of 08 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Apr 2022
- Registered office
- 2400 Mol
- Size
- Small · 24.2 FTE
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
PanTera (SA) has been based in Mol since 2022, active in: manufacture of other pharmaceutical products. For 2025, it reports revenue of €13.3m, a net loss of €3.91m and equity of €108.8m. With 24.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 94.0%, above the median of its sector (47.2%).
Companies similar to PanTera
Companies in the same business, of comparable size and area, outside its group.
- Telix Pharmaceuticals (Belgium) Manufacture of pharmaceutical preparations Seneffe · balance sheet €57.1m
- IRE ELiT Manufacture of pharmaceutical preparations Fleurus · balance sheet €19.5m
- Trasis Engineering activities and related technical consultancy Ans · balance sheet €94.7m
- Siemens Healthcare Manufacture of medical and dental instruments and supplies Dilbeek · balance sheet €109.3m
- Biocartis Research and experimental development on natural sciences and engineering Mechelen · balance sheet €61.8m
- Henogen Technical testing and analysis Charleroi · balance sheet €97.2m
- Bruker Belgium Manufacture of instruments and appliances for measuring, testing and navigation Kontich · balance sheet €56.3m
- Medgenix Benelux Manufacture of pharmaceutical preparations Wevelgem · balance sheet €39.4m
Frequently asked questions about PanTera
What is the revenue of PanTera?
According to the 2025 annual accounts filed with the NBB, the revenue of PanTera amounts to 13,277,221 €.
What is the VAT number of PanTera?
In Belgium, the VAT number is the company number prefixed with BE: BE0784992591 for PanTera, if the company is VAT-registered. Its company number (CBE) is 0784.992.591.
Where is the registered office of PanTera?
According to the CBE register, the registered office of PanTera is in 2400 Mol.
What is the equity of PanTera?
At the close of the 2025 financial year, the equity of PanTera amounts to 108,809,235 €, a solvency of 94.0% of total assets.
How many people work at PanTera?
24.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages PanTera?
The register lists 9 active mandates at PanTera. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PanTera
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →